Treatment Strategies

Following presentation and diagnosis of NSCLC, thorough examination allows determination of the disease stage to provide a prognosis at the individual patient level. Ideally, the aim of any intervention or treatment is to improve the prognosis of the patient. The choice of treatment is dependent on the disease stage, the medical history of the patient and general state of health. The patient’s wishes must also be considered. This section will describe how decisions are made concerning the overall treatment strategy, the roles, advantages and disadvantages of surgery, radiotherapy and chemotherapy, and the potential offered by the new, targeted therapies.

Overall strategy

The treatment strategies for NSCLC are principally dictated by clinical stage with modulation according to patient preferences and characteristics such as age and PS (Figure 1).

Figure 1. Lung cancer: stage at diagnosis, treatment, and 5-year survival rates.

Stage at diagnosis, treatment and 5yr survival rate

Please Log in
Free registration to access disease diagnosis, patient management, physician tools.

Only registered users have access to this content.

Already Registered?

Email    Password   

Not a member?

Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students. 

Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major theraputic areas, disease management, and clinical tools.

As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!

REGISTER today it only takes a minute! and it's FREE

If you are not a healthcare professional please visit our patient site.

Having problems?

Use our forgotten password facility or email us at: contact@epgonline.org

Exit Log in